TokenPost·
Bristol Myers Discloses Septic Pneumonia Death in MS Trial
The patient had highly active relapsing MS and developed late-onset, non-ICANS motor symptoms before receiving high-dose cyclophosphamide the day before death.
More news
- TokenPostGlobal X Sets CAD 0.02930 October Payout for Bond ETF
- TokenPostGlobal X Growth Asset Allocation Covered Call ETF Declares CAD 0.17 Monthly Dividend
- TokenPostGlobal X Raises HMP Monthly Distribution to CAD 0.02960
- TokenPostGlobal X Active Corporate Bond ETF Sets CAD 0.035 Dividend
- TokenPostStrategy Adds 267 Bitcoin, Lifting Holdings to 848,517
- TokenPostGlobal X Sets C$0.04540 Monthly Distribution for HYBR ETF